Castory Munishi
Overview
Explore the profile of Castory Munishi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mwamwitwa K, Bukundi E, Maganda B, Munishi C, Fimbo A, Buma D, et al.
Inquiry
. 2024 Sep;
61:469580241273323.
PMID: 39279290
The use of chiral medicines (possessing center(s) of asymmetric carbon) may cause adverse drug reactions (ADRs). The safety assurance of these medicines is critical. We aimed to evaluate registered and...
2.
Amani D, Ndumwa H, Ngowi J, Njiro B, Munishi C, Mboya E, et al.
Ann Glob Health
. 2024 Mar;
90(1):18.
PMID: 38463453
Background: Non-communicable diseases (NCDs) arise from diverse risk factors with differences in the contexts and variabilities in regions and countries. Addressing such a complex challenge requires local evidence. Tanzania has...
3.
Sunguya B, Ngowi J, Njiro B, Munishi C, Ndumwa H, Kengia J, et al.
BMJ Open
. 2024 Feb;
14(2):e073859.
PMID: 38373858
Objective: This study aimed to document lessons learnt and best practices for scaling up an innovative emergency transportation system, drawing insights from the m-mama programme implemented in Shinyanga, Tanzania. The...
4.
Safary E, Beran D, Vetter B, Lepeska M, Abdraimova A, Dunganova A, et al.
BMJ Open
. 2024 Feb;
14(2):e076685.
PMID: 38367964
Aims: Development of non-invasive and minimally invasive glucose monitoring devices (NI-MI-GMDs) generally takes place in high-income countries (HICs), with HIC's attributes guiding product characteristics. However, people living with diabetes (PLWD)...
5.
Maganda B, Munishi C, Mlyuka H, Mlugu E, Mohamedi J, Mwamwitwa K
Hosp Pharm
. 2024 Jan;
59(1):86-93.
PMID: 38223861
The burden of renal diseases is increasing in developing countries like Tanzania. Drug accumulation exposes patients with renal impairment to drug toxicity that may lead to adverse drug reactions, poor...
6.
Fimbo A, Mwalwisi Y, Mwamwitwa K, Matiko D, Mfinanga E, Lyimo J, et al.
Sci Rep
. 2024 Jan;
14(1):615.
PMID: 38182720
Tanzania adopted a Dolutegravir (DTG)-based regimen as first-line treatment in 2019 following the World Health Organization recommendation. Data on the DTG safety profile from sub-Saharan Africa including Tanzania are limited....
7.
Njiro B, Ngowi J, Ndumwa H, Amani D, Munishi C, Mloka D, et al.
Ann Glob Health
. 2023 Dec;
89(1):89.
PMID: 38107601
Background: Five million people die every year from non-communicable diseases (NCDs) globally. In Tanzania, more than two-thirds of deaths are NCD-related. The country is investing in preventive and advocacy activities...
8.
Ngowi J, Munishi C, Ndumwa H, Njiro B, Amani D, Mboya E, et al.
Ann Glob Health
. 2023 Nov;
89(1):78.
PMID: 38025922
No abstract available.
9.
Ndumwa H, Amani D, Ngowi J, Njiro B, Munishi C, Mboya E, et al.
Ann Glob Health
. 2023 Nov;
89(1):77.
PMID: 38025921
Background: The burden of Non-Communicable Diseases (NCDs) is rapidly increasing globally, and low- and middle-income countries (LMICs) bear the brunt of it. Tanzania is no exception. Addressing the rising burden...
10.
Munishi C, Ndumwa H, Massawe J, Njiro B, Ngowi J, Suhartono S, et al.
PLOS Digit Health
. 2023 Sep;
2(9):e0000257.
PMID: 37756266
Evidence on the additional benefit in treatment and recovery process among PWDUD using digital health interventions is lacking. This study aimed to describe the acceptability of using a digital intervention...